AXA Upbeat on 2025 Earnings as Premiums Rise Across Business
By Joshua Kirby
AXA posted a rise in revenue for the first nine months of the year as premiums increased across divisions, and backed its growth target for the year.
The French insurer said Thursday that gross written premiums--a measure of commercial activity in insurance--and other revenue climbed 6% on year to 89.4 billion euros ($103.7 billion.)
That increase reflects a step-up in business in both the property & casualty division and the life & health division, with premiums rising by 4% and 11%, respectively, compared with the first nine months of 2024, AXA said.
The group's Solvency II ratio, a measure of financial strength, stood at 222% as of Sept. 30, up two points from the end of the previous quarter and one point from the 221% reported at the same point last year. AXA pointed to a stronger operating return and the 5.1 billion-euro sale this year of its investment-management arm to French bank BNP Paribas among reasons for the stronger ratio.
"In the current volatile environment, AXA's diversified business model and its solid balance sheet ... are a source of strength," Chief Financial Officer Alban de Mailly Nesle said.
For 2025 as a whole, AXA said it still expects to post growth in its underlying earnings per share in line with a target of 6%-8% compound annual growth between 2023 and next year.
"We remain confident in our strategy and are focused on the execution of our current plan," De Mailly Nesle said.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
October 30, 2025 12:59 ET (16:59 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
